Skye Bioscience Inc (SKYE)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 10-2012 | 12-2011 | 12-2006 | 12-2005 | |
| Assets | ||||
| Current Assets | ||||
| Cash & Cash Equivalents | 26 | 26 | N/A | N/A |
| Receivables | 7 | 7 | N/A | N/A |
| Other current assets | 5 | 5 | 0 | 0 |
| TOTAL | $38 | $38 | $N/A | $N/A |
| Non-Current Assets | ||||
| Other Non-Current Assets | 5 | 0 | 0 | 0 |
| TOTAL | $5 | $N/A | $N/A | $N/A |
| Total Assets | $43 | $43 | $N/A | $N/A |
| Liabilities | ||||
| Current Liabilities | ||||
| Accounts payable and accrued liabilities | 4 | 0 | 0 | 0 |
| TOTAL | $4 | $4 | $N/A | $N/A |
| Non-Current Liabilities | ||||
| TOTAL | $N/A | $N/A | $N/A | $N/A |
| Total Liabilities | $4 | $4 | $N/A | $N/A |
| Shareholders' Equity | ||||
| Common Shares | 3 | N/A | N/A | N/A |
| Retained earnings | 1 | 1 | N/A | N/A |
| Other shareholders' equity | 0 | 38 | 0 | 0 |
| TOTAL | $39 | $39 | $N/A | $N/A |
| Total Liabilities And Equity | $43 | $43 | $0 | $0 |